INVESTOR AGREEMENTInvestor Agreement • May 10th, 2018 • Nektar Therapeutics • Pharmaceutical preparations • Delaware
Contract Type FiledMay 10th, 2018 Company Industry JurisdictionThis INVESTOR AGREEMENT (this “Agreement”) is made as of February 13, 2018, by and between Bristol-Myers Squibb Company, a Delaware corporation (the “Investor”), and Nektar Therapeutics, a Delaware corporation (the “Company”).
STRATEGIC COLLABORATION AGREEMENTStrategic Collaboration Agreement • May 10th, 2018 • Nektar Therapeutics • Pharmaceutical preparations • New York
Contract Type FiledMay 10th, 2018 Company Industry Jurisdiction[***] Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions.